MicroRNA-induced IgA nephropathy

Journal of the American Society of Nephrology

Volumn 23, Issue 5, 2012, Pages 765-766

  Imai, Enyu ^a   Maruyama, Shoichi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA CRYSTALLIN; GALACTOSE; GALACTOSYLTRANSFERASE; IMMUNOGLOBULIN A1; MICRORNA; N ACETYLGALACTOSAMINE; SIALIC ACID; SMAD PROTEIN; THREONINE; TRANSFORMING GROWTH FACTOR BETA;

B LYMPHOCYTE; CELL IMMORTALIZATION; EDITORIAL; ENZYME ACTIVITY; ENZYME BINDING; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MESANGIUM CELL; MICRORNA INDUCED IMMUNOGLOBULIN A NEPHROPATHY; MOLECULAR PATHOLOGY; PREVALENCE; PRIORITY JOURNAL; PROTEIN INDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84860631979     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012030249     Document Type: Editorial

References (20)

1. D'Amico G: The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 64: 709-727, 1987
2. Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, Tsuruya K, Kiyomoto H, Iida H, Sasaki T, Higuchi M, Hattori M, Oka K, Kagami S, Nagata M, Kawamura T, Honda M, Fukasawa Y, Fukatsu A, Morozumi K, Yoshikawa N, Yuzawa Y, Matsuo S, Kiyohara Y, Joh K, Taguchi T, Makino H; Committee for Standardization of Renal Pathological Diagnosis and Working Group for Renal Biopsy Database, Japanese Society of Nephrology, Tokyo, Japan: Japan Renal Biopsy Registry: The first nationwide, web-based, and prospective registry system of renal biopsies in Japan. Clin Exp Nephrol 15: 493-503, 2011
3. Suzuki K, Honda K, Tanabe K, Toma H, Nihei H, Yamaguchi Y: Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 63: 2286-2294, 2003 (Pubitemid 36605844)
4. D'Amico G: Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: Survey of the recent literature. Am J Kidney Dis 20: 315-323, 1992
5. Koyama A, Igarashi M, Kobayashi M; Research Group on Progressive Renal Diseases: Natural history and risk factors for immunoglobulin A nephropathy in Japan. Am J Kidney Dis 29: 526-532, 1997 (Pubitemid 27155272)
6. Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB, Wyatt RJ, Scolari F, Mestecky J, Gharavi AG, Julian BA: The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22: 1795-1803, 2011
7. Floege J: The pathogenesis of IgA nephropathy: What is new and how does it change therapeutic approaches? Am J Kidney Dis 58: 992-1004, 2011
8. Allen AC, Topham PS, Harper SJ, Feehally J: Leucocyte beta 1,3 galactosyltransferase activity in IgA nephropathy. Nephrol Dial Transplant 12: 701-706, 1997 (Pubitemid 27170423)
9. Suzuki H, Moldoveanu Z, Hall S, Brown R, Vu HL, Novak L, Julian BA, Tomana M, Wyatt RJ, Edberg JC, Alarcón GS, Kimberly RP, Tomino Y, Mestecky J, Novak J: IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest 118: 629-639, 2008 (Pubitemid 351206552)
10. Inoue T, Sugiyama H, Hiki Y, Takiue K, Morinaga H, Kitagawa M, Maeshima Y, Fukushima K, Nishizaki K, Akagi H, Narimatsu Y, Narimatsu H, Makino H: Differential expression of glycogenes in tonsillar B lymphocytes in association with proteinuria and renal dysfunction in IgA nephropathy. Clin Immunol 136: 447-455, 2010
11. Serino G, Sallustio F, Cox SN, Pesce F, Schena FP: Abnormal miR-418b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy. J Am Soc Nephrol 23: 814-824, 2012
12. Pirulli D, Crovella S, Ulivi S, Zadro C, Bertok S, Rendine S, Scolari F, Foramitti M, Ravani P, Roccatello D, Savoldi S, CerulloG, Lanzilotta SG, Bisceglia L, Zelante L, Floege J, Alexopoulos E, Kirmizis D, Ghiggeri GM, Frascà G, Schena FP, Amoroso A; European IgAN Consortium: Genetic variant of C1GalT1 contributes to the susceptibility to IgA nephropathy. J Nephrol 22: 152-159, 2009
13. LiGS, Zhang H, Lv JC, Shen Y, Wang HY: Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy. Kidney Int 71: 448-453, 2007
14. Chandrasekaran K, Karolina DS, Sepramaniam S, Armugam A, Wintour EM, Bertram JF, Jeyaseelan K: Role of microRNAs in kidney homeostasis and disease. Kidney Int 81: 617-627, 2012
15. Wong GL, Wong VW, Tan GM, Ip KI, Lai WK, Li YW, Mak MS, Lai PB, Sung JJ, Chan HL: Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis. Liver Int 28: 79-87, 2008
16. Smith AC, deWolff JF, Molyneux K, Feehally J, Barratt J: O-glycosylation of serum IgD in IgA nephropathy. J Am Soc Nephrol 17: 1192-1199, 2006
17. Smith AC, Molyneux K, Feehally J, Barratt J: O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J Am Soc Nephrol 17: 3520-3528, 2006 (Pubitemid 44865295)
18. Yamada K, Kobayashi N, Ikeda T, Suzuki Y, Tsuge T, Horikoshi S, Emancipator SN, Tomino Y: Down-regulation of core 1 beta1,3- galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1. Nephrol Dial Transplant 25: 3890-3897, 2010
19. Anglicheau D, Sharma VK, Ding R, Hummel A, Snopkowski C, Dadhania D, Seshan SV, Suthanthiran M: MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci USA 106: 5330-5335, 2009
20. van Rooij E, Purcell AL, Levin AA: Developing microRNA therapeutics. Circ Res 110: 496-507, 2012